MedRhythms has filed a notice of an exempt offering of securities to raise $8,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, MedRhythms is raising $8,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brian Harris played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About MedRhythms
MedRhythms is developing next-generation neurotherapeutics that leverage the power of music and technology to redefine whats possible in brain health, for patients around the world. Our devices are designed to improve walking, mobility and related functional outcomes via a proprietary, patented technology platform. This platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. We are developing a pipeline of digital therapeutics across a range of neurological conditions, including stroke, multiple sclerosis and Parkinsons disease.
To learn more about MedRhythms, visit http://www.medrhythms.com/
Contact:
Brian Harris, Chief Executive Officer
617-356-7822
https://www.linkedin.com/in/brian-harris-a4a31921/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.